Literature DB >> 2502462

Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes.

L Al-Sakkaf1, P Pozzilli, A C Tarn, G Schwarz, E A Gale, G F Bottazzo.   

Abstract

Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502462     DOI: 10.1007/bf00265550

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes.

Authors:  P Pozzilli; P Arduini; N Visalli; J Sutherland; M Pezzella; C Galli; S G Corradini; L Biasio; E A Gale; D Andreani
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 4.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

5.  Type I (insulin dependent) diabetes: a disease of slow clinical onset?

Authors:  A C Tarn; C P Smith; K M Spencer; G F Bottazzo; E A Gale
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

6.  Lymphocyte subsets and activation in prediabetes.

Authors:  C L Hitchcock; W J Riley; A Alamo; R Pyka; N K Maclaren
Journal:  Diabetes       Date:  1986-12       Impact factor: 9.461

7.  Culture and phenotype of activated T-cells from patients with type I diabetes mellitus.

Authors:  A R Hayward; M Herberger
Journal:  Diabetes       Date:  1984-04       Impact factor: 9.461

8.  Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes.

Authors:  P Pozzilli; O Zuccarini; M Iavicoli; D Andreani; M Sensi; K M Spencer; G F Bottazzo; P C Beverley; J L Kyner; A G Cudworth
Journal:  Diabetes       Date:  1983-01       Impact factor: 9.461

9.  Prospective study of lymphocyte subsets in subjects genetically susceptible to type 1 (insulin-dependent) diabetes.

Authors:  P Pozzilli; M Sensi; L Al-Sakkaf; A Tarn; O Zuccarini; G F Bottazzo
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

  9 in total
  14 in total

Review 1.  T-cell reactivity to beta-cell antigens in human insulin-dependent (type 1) diabetes mellitus. Implications for diagnosis and therapy.

Authors:  B O Roep
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Early T-cell defects in pre-type 1 diabetes.

Authors:  L al Sakkaf; P Pozzilli; P J Bingley; M W Lowdell; J M Thomas; E Bonifacio; E A Gale; G F Bottazzo
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

Review 3.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 4.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 5.  The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Authors:  Bart O Roep
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

6.  Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.

Authors:  J Ilonen; H M Surcel; M L Käär
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

7.  High serum levels of soluble CD8 in insulin-dependent diabetes.

Authors:  E Di Cesare; M Previti; M C Ingemi; G F Bagnato; D Cucinotta
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.

Authors:  R Y Tun; M Peakman; L Alviggi; M J Hussain; S S Lo; M Shattock; D A Pyke; G F Bottazzo; D Vergani; R D Leslie
Journal:  BMJ       Date:  1994-04-23

9.  Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.

Authors:  C Giordano; R De Maria; M Todaro; G Stassi; A Mattina; P Richiusa; G Galluzzo; F Pantó; A Galluzzo
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

10.  A variable CD3⁺ T-cell frequency in peripheral blood lymphocytes associated with type 1 diabetes mellitus development in the LEW.1AR1-iddm rat.

Authors:  Tanja Arndt; Anne Jörns; Heike Weiss; Markus Tiedge; Hans-Jürgen Hedrich; Sigurd Lenzen; Dirk Wedekind
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.